AAAAAA

   
Results: 1-15 |
Results: 15
Predictive relevance of soluble CD44v6 serum levels for the responsivenessto second line hormone- or chemotherapy in patients with metastatic breastcancer
Authors: Kopp, R Classen, S Wolf, H Gholam, P Possinger, K Eiermann, W Wilmanns, W
Citation: R. Kopp et al., Predictive relevance of soluble CD44v6 serum levels for the responsivenessto second line hormone- or chemotherapy in patients with metastatic breastcancer, ANTICANC R, 21(4B), 2001, pp. 2995-3000
Local immunotherapy of glioma patients with a combination of 2 bispecific antibody fragments and resting autologous lymphocytes: Evidence for in situT-cell activation and therapeutic efficacy
Authors: Jung, G Brandl, M Eisner, W Fraunberger, P Reifenbeger, G Schlegel, U Wiestler, OD Reulen, FJ Wilmanns, W
Citation: G. Jung et al., Local immunotherapy of glioma patients with a combination of 2 bispecific antibody fragments and resting autologous lymphocytes: Evidence for in situT-cell activation and therapeutic efficacy, INT J CANC, 91(2), 2001, pp. 225-230
Prognostic significance of increased IL-10 production in patients prior toallogeneic bone marrow transplantation
Authors: Holler, E Roncarolo, MG Hintermeier-Knabe, R Eissner, G Ertl, B Schulz, U Knabe, H Kolb, HJ Andreesen, R Wilmanns, W
Citation: E. Holler et al., Prognostic significance of increased IL-10 production in patients prior toallogeneic bone marrow transplantation, BONE MAR TR, 25(3), 2000, pp. 237-241
p53-immunoreactive cells in benign and malignant effusions: Diagnostic value using a panel of monoclonal antibodies and comparison with CEA-staining
Authors: Stoetzer, OJ Munker, R Darsow, M Wilmanns, W
Citation: Oj. Stoetzer et al., p53-immunoreactive cells in benign and malignant effusions: Diagnostic value using a panel of monoclonal antibodies and comparison with CEA-staining, ONCOL REP, 6(2), 1999, pp. 455-458
Second malignancies after Hodgkin's disease: the Munich experience
Authors: Munker, R Grutzner, S Hiller, E Aydemir, U Enne, W Dietzfelbinger, H Busch, M Haas, R Emmerich, B Schmidt, M Duhmke, E Holzel, D Wilmanns, W
Citation: R. Munker et al., Second malignancies after Hodgkin's disease: the Munich experience, ANN HEMATOL, 78(12), 1999, pp. 544-554
GM-CSF stimulates proliferation of clonal leukemic bone marrow cells in acute myeloid leukemia (AML) in vitro
Authors: Schmetzer, HM Gerhartz, HH Wilmanns, W
Citation: Hm. Schmetzer et al., GM-CSF stimulates proliferation of clonal leukemic bone marrow cells in acute myeloid leukemia (AML) in vitro, ANN HEMATOL, 78(10), 1999, pp. 449-455
Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemiacell lines
Authors: Nuessler, V Stotzer, O Gullis, E Pelka-Fleischer, R Pogrebniak, A Gieseler, F Wilmanns, W
Citation: V. Nuessler et al., Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemiacell lines, LEUKEMIA, 13(11), 1999, pp. 1864-1872
Drug-induced apoptosis in chronic lymphocytic leukemia
Authors: Stoetzer, OJ Pogrebniak, A Scholz, M Pelka-Fleischer, R Gullis, E Darsow, M Nussler, V Wilmanns, W
Citation: Oj. Stoetzer et al., Drug-induced apoptosis in chronic lymphocytic leukemia, LEUKEMIA, 13(11), 1999, pp. 1873-1880
Human parvovirus B19-associated disease in bone marrow transplantation
Authors: Schleuning, M Jager, G Holler, E Hill, W Thomssen, C Denzlinger, C Lorenz, T Ledderose, G Wilmanns, W Kolb, HJ
Citation: M. Schleuning et al., Human parvovirus B19-associated disease in bone marrow transplantation, INFECTION, 27(2), 1999, pp. 114-117
Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusions
Authors: Lamerz, R Stoetzer, OJ Mezger, J Brandt, A Darsow, M Wilmanns, W
Citation: R. Lamerz et al., Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusions, ANTICANC R, 19(4A), 1999, pp. 2421-2425
Determination of thymidine phosphorylase activity in leukemic blast cells by a high-performance liquid-chromatographic assay
Authors: Nuessler, V Pogrebniak, A Pelka-Fleischer, R Boos, K Wilmanns, W
Citation: V. Nuessler et al., Determination of thymidine phosphorylase activity in leukemic blast cells by a high-performance liquid-chromatographic assay, CHROMATOGR, 49(3-4), 1999, pp. 173-178
In vitro efficacy of known P-glycoprotein modulators compared to droloxifene E and Z: Studies on a human T-cell leukemia cell line and their resistant variants
Authors: Nussler, V Pelka-Fleisc, R Gieseler, F Hasmann, M Loser, R Gullis, E Stotzer, O Zwierzina, H Wilmanns, W
Citation: V. Nussler et al., In vitro efficacy of known P-glycoprotein modulators compared to droloxifene E and Z: Studies on a human T-cell leukemia cell line and their resistant variants, LEUK LYMPH, 31(5-6), 1998, pp. 589-597
Organization of preclinical and clinical research on anticancer therapy with biological response modifiers (BRMs)
Authors: Zwierzina, H Caligaris-Cappio, F Connors, T D'Incalci, M Double, J Hendriks, H Leake, R Newell, H Willemze, R Wilmanns, W
Citation: H. Zwierzina et al., Organization of preclinical and clinical research on anticancer therapy with biological response modifiers (BRMs), BIOM HLTH R, 24, 1998, pp. 240-244
Cytokines in GvH and GvL
Authors: Holler, E Kolb, HJ Eissner, G Wilmanns, W
Citation: E. Holler et al., Cytokines in GvH and GvL, BONE MAR TR, 22, 1998, pp. S3-S6
Cloning and characterization of bone marrow cells from patients with acutelymphoid leukemia (ALL) in agar cultures
Authors: Schmetzer, H Muller, C Wilmanns, W Gerhartz, H
Citation: H. Schmetzer et al., Cloning and characterization of bone marrow cells from patients with acutelymphoid leukemia (ALL) in agar cultures, HAEMATOLOGI, 29(3), 1998, pp. 195-205
Risultati: 1-15 |